Log In
BCIQ
Print this Print this
 

Oral lasmiditan (Oral COL-144)

Also known as: formerly IY573144

  Manage Alerts
Collapse Summary General Information
Company CoLucid Pharmaceuticals Inc.
DescriptionSelective agonist of serotonin (5-HT1F) receptor
Molecular Target Serotonin (5-HT1F) receptor
Mechanism of ActionSerotonin (5-HT1F) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationMigraine
Indication DetailsTreat acute migraine
Regulatory Designation U.S. - Special Protocol Assessment (Treat acute migraine)
PartnerIldong Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/28/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today